Certara acquired BaseCase for $25.3 million, a transaction completed in January 2018, structured as all cash (funded by term debt + cash on hand).
BaseCase operates in Software. BaseCase is a SaaS company serving the life sciences industry, providing tools for building interactive value-communication and market-access materials used by commercial and medical teams. Certara acquired 100% of BaseCase's equity, adding cloud-based content and value-messaging capability to its market-access and evidence offering. The $25.3 million purchase price was funded with $25.0 million of additional term-loan proceeds plus cash on hand.
Extend Certara's market-access and evidence platform with cloud-based value-communication software for life-sciences commercial teams.
Advisory firms were not disclosed for this transaction.